Private Equity

Updated:

Hongsen Investment

Hongsen Investment is a venture capital fund focused on the pharmaceutical industry. It has made eight investments to date. Its most recent investment was in...

Hongsen Investment logo

Hongsen Investment

Hongsen Investment is a venture capital fund focused on the pharmaceutical industry. It has made eight investments to date. Its most recent investment was in YL Pharma as part of their Series A funding on February 2, 2021.

General information

Firm type

Private Equity

Year founded

2020

Location

Region

Asia

Country

Hong Kong

City

Hong Kong

Corporate office

Hong Kong, Hong Kong

Principals

Fang Fenglei

Founding Partner & Chairman

Sector focus

Financial ServicesNatural ResourcesConsumer

Frequently asked questions

Who runs investment decisions at Hongsen Investment?

Fang Fenglei, the founding partner and chairman, directs investment decisions at Hongsen. Fang is one of China's most consequential financial dealmakers — he co-founded China International Capital Corporation (CICC) in 1995 and later chaired Goldman Sachs's onshore securities joint venture, Goldman Sachs Gao Hua. His personal relationships with China's sovereign capital institutions and corporate leadership form the core of the firm's deal origination and decision-making process.

How is Hongsen Investment related to Hopu Investment Management?

Hongsen Investment is a parallel platform established by Fang Fenglei after he built Hopu Investment Management in 2007. While Hopu raised capital from marquee international investors including Temasek and Goldman Sachs to pursue large-scale state-owned enterprise restructurings, Hongsen operates with a more streamlined structure targeting concentrated positions. The two platforms share a common founder and investment philosophy but are managed as distinct entities.

Does Hongsen Investment participate in fund commitments or only direct deals?

Hongsen primarily executes direct equity investments rather than operating as a fund-of-funds allocator. The firm's strategy centers on taking control or significant minority stakes in operating companies, predominantly within mainland China. Public records do not indicate meaningful fund commitment activity to external GPs.

Which sectors does Hongsen Investment typically target?

Hongsen concentrates on financial services, natural resources, and consumer sectors within Greater China. The firm's investment thesis consistently targets industries where Chinese policy objectives — such as financial sector reform, commodity security, and domestic consumption growth — create structural advantages for well-positioned incumbents and restructuring candidates.

What is Hongsen Investment's known posture on co-investments alongside external partners?

Historical deal patterns across Fang Fenglei's platforms indicate a willingness to co-invest alongside sovereign wealth funds and state-owned financial institutions, particularly when executing large-scale restructurings. Fang's personal relationships with international institutions like Temasek, cultivated over decades, have traditionally provided co-investment capacity, though Hongsen's specific current co-investment practices are not publicly documented.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Hong Kong Private Equity profiles